Cancer Research Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 1938-1942, August 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boggs, S. S.
Right arrow Articles by DeMezza, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boggs, S. S.
Right arrow Articles by DeMezza, A.

Minimal Bone Marrow Damage in Mice Given Bleomycin1

Sallie S. Boggs2, George P. Sartiano and Angelo DeMezza

Division of Hematology, Department of Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15261

The effects of bleomycin on several parameters of hematopoiesis were studied. Large single or repeated doses of from 0.5 to 3 mg/mouse were given to normal mice at various times before irradiation and/or marrow donation.

A single injection of 2 mg bleomycin caused no change in the total number of nucleated cells per humerus, but when cells from these humeri were injected into lethally irradiated recipients, there was a decrease in spleen weight, 59Fe uptake, and colony numbers, compared with 0.9% NaCl solution-injected controls. When donor mice were given 3 daily injections of 1 mg bleomycin and were killed 2, 5, 7, 9, and 12 days later, the mean numbers of blood lymphocytes and nucleated cells per humerus were reduced. Recipients of marrow from these mice had both lower spleen weight and 59Fe uptake and fewer colonies 8 days after irradiation than did recipients of control cells. These reductions were small (minimal values were > 30% of control), but they persisted and even became somewhat larger as the interval after injection of bleomycin increased through 12 days.

The effects of combining bleomycin with irradiation were similar. Colony number, spleen weight, and spleen 59Fe were reduced but did not fall below 37% of control. At most of the doses of bleomycin and times of injection relative to irradiation used in these experiments, some decrease in the hematopoietic parameters was observed. However, no consistent relationship of these alterations to dose or time of administration was seen. Thus, bleomycin has minimal but definite effects on those parameters of murine hematopoiesis measured in these experiments.

1 This work was supported by Research Grant AM 14352-05 from the National Institute of Arthritis and Metabolic Diseases.

2 Special Fellow of the Leukemia Society of America.

Received 12/21/73. Accepted 4/10/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.